Dr. Cohen is currently Professor of Medicine at the University of Missouri-Kansas City and Director of Cardiovascular Research at Saint Luke’s Mid America Heart Institute.  In addition, he is Medical Director of the Medical Economics and Technology Assessment Group at the Mid America Heart Institute (MAHI).  Dr. Cohen’s research focuses on the application of formal cost-effectiveness methodology to novel interventions for the diagnosis and treatment of cardiovascular disease, the extension of traditional cardiovascular outcomes research to include collection of patient-centered outcomes among patients undergoing treatment for cardiovascular disease, the development and evaluation of instruments for evaluating health status and preference among patients with cardiovascular disease.  He is also active in research to determine the short- and long-term outcomes of new devices for percutaneous coronary revascularization and identifying the optimal target populations and techniques for these devices.